Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
ARNA [NASD]
Arena Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own0.70% Shs Outstand219.26M Perf Week-2.99%
Market Cap1.35B Forward P/E- EPS next Y-0.26 Insider Trans10.43% Shs Float217.90M Perf Month2.33%
Income-19.40M PEG- EPS next Q-0.10 Inst Own49.30% Short Float24.32% Perf Quarter-17.76%
Sales81.40M P/S16.59 EPS this Y80.00% Inst Trans0.10% Short Ratio9.55 Perf Half Y40.32%
Book/sh0.42 P/B14.67 EPS next Y36.60% ROA-6.80% Target Price7.83 Perf Year-22.42%
Cash/sh1.01 P/C6.09 EPS next 5Y- ROE-19.10% 52W Range4.05 - 9.25 Perf YTD5.30%
Dividend- P/FCF21.27 EPS past 5Y51.20% ROI-13.90% 52W High-33.41% Beta-0.33
Dividend %- Quick Ratio3.30 Sales past 5Y52.70% Gross Margin92.40% 52W Low52.10% ATR0.28
Employees310 Current Ratio3.50 Sales Q/Q242.10% Oper. Margin-20.80% RSI (14)44.25 Volatility3.34% 4.73%
OptionableYes Debt/Eq0.79 EPS Q/Q-10.00% Profit Margin-24.00% Rel Volume0.87 Prev Close6.34
ShortableYes LT Debt/Eq0.77 EarningsFeb 27 AMC Payout- Avg Volume5.55M Price6.16
Recom2.60 SMA20-2.14% SMA50-6.35% SMA200-0.22% Volume4,822,335 Change-2.84%
15-Nov-13Initiated WallachBeth Buy $9
03-Oct-13Initiated Cowen Market Perform $4.50
25-Oct-10Reiterated Barclays Capital Underweight $3 → $2
20-Sep-10Reiterated UBS Neutral $7 → $2
17-Sep-10Downgrade Davenport Buy → Neutral
14-Sep-10Downgrade Barclays Capital Equal Weight → Underweight $4 → $3
23-Aug-10Reiterated UBS Neutral $3.50 → $7
16-Jul-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1
02-Jul-10Reiterated UBS Buy $40 → $38
04-Feb-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
17-Dec-09Initiated Jefferies & Co Hold $4
21-Sep-09Downgrade Leerink Swann Outperform → Mkt Perform $6
18-Sep-09Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $3
15-Sep-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
18-Aug-09Initiated JMP Securities Mkt Perform
24-Jun-09Initiated Rodman & Renshaw Mkt Outperform $9
16-Mar-09Downgrade Canaccord Adams Hold → Sell
18-Feb-09Downgrade UBS Buy → Neutral $6 → $7
18-Feb-09Downgrade UBS Buy → Neutral
10-Dec-08Reiterated UBS Buy $8 → $6
21-Apr-14 11:13AM  Arena Pharmaceuticals' Belviq Sales Dip - Why? at Seeking Alpha
16-Apr-14 06:00AM  'Mad Money' Lightning Round: Delta Is Flying to $40 at TheStreet
15-Apr-14 08:08PM  Jim Cramer's 'Mad Money' Recap: Fear and Loathing on Wall Street at TheStreet
14-Apr-14 05:58PM  Biotech Tweet of the Week: Love Being Private at Motley Fool
09:22AM  What Arena's Belviq Television Ad Campaign Means For The Stock at Seeking Alpha
08:33AM  Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management PR Newswire
11-Apr-14 01:54PM  Arena - Belviq Sales Up Modestly Heading Into Television Ads at Seeking Alpha
04-Apr-14 03:07PM  Arena Script Sales Close Out Quarter On Positive Note at Seeking Alpha
03-Apr-14 12:40PM  VIVUS retreats after analyst cuts rating to sell equivalent at theflyonthewall.com
02-Apr-14 09:05AM  MannKind Doubles on FDA News, Could Drive Short Covering in Biotech Sector at Minyanville
31-Mar-14 02:56PM  Does Arena Pharmaceuticals Have An Anti-Smoking Opportunity? at Motley Fool
28-Mar-14 12:25PM  Arena - Scripts, Ads, Sales Reps at Seeking Alpha
27-Mar-14 08:31AM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
24-Mar-14 09:34AM  Direct-To-Consumer Television Advertising Marks The Tipping Point For Belviq Sales at Seeking Alpha
21-Mar-14 06:31PM  Does Mannkind Offer a Good Risk to Reward Ratio? at Motley Fool
20-Mar-14 06:36PM  March Madness: Final Four Investing Bracket 2014 at Seeking Alpha
17-Mar-14 08:27AM  Arena Down With Overall Market - Sales Data No Help at Seeking Alpha
14-Mar-14 11:15PM  [$$] What's News: World-Wide at The Wall Street Journal
13-Mar-14 10:13AM  Could Orexigen Therapeutics Be Another Arena or VIVUS? at Motley Fool -6.44%
10:13AM  Could Orexigen Therapeutics Be Another Arena or VIVUS?
11-Mar-14 07:33AM  Leaked ad explains why HTC's putting a 'Duo Camera' in its new One at Engadget
07:33AM  Leaked ad explains why HTC's putting a 'Duo Camera' in its new One
08-Mar-14 01:04PM  ARENA PHARMACEUTICALS INC Financials EDGAR Online Financials
07-Mar-14 04:01PM  Arena Sees Growth Continue With Belviq at Seeking Alpha
04:01PM  Arena Sees Growth Continue With Belviq
03:09PM  Have Anti-Obesity Drug Companies Failed? at Seeking Alpha
03:09PM  Have Anti-Obesity Drug Companies Failed?
06-Mar-14 07:43AM  The Zacks Analyst Blog Highlights: InterMune, Alexion, Regeneron, VIVUS and Arena Zacks
04-Mar-14 02:05PM  Have Anti-Obesity Drug Prospects Finally Gone Belly-Up? at Motley Fool
02:05PM  Have Anti-Obesity Drug Prospects Finally Gone Belly-Up?
08:23AM  Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)? Zacks
08:23AM  Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)?
03-Mar-14 04:49PM  ARENA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
09:26AM  Company news for March 03, 2014 Zacks
09:26AM  Company news for March 03, 2014
08:01AM  Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value at Seeking Alpha
08:01AM  Future Sales Of Arena Pharmaceuticals' Belviq: Let's Make Some Informed, Quantitative Predictions Using Expected Value at Seeking Alpha
08:01AM  Future Sales Of Arena Pharmaceuticals' Belviq: Let's Make Some Informed, Quantitative Predictions Using Expected Value
28-Feb-14 09:19PM  Arena Pharmaceuticals, Inc. Down for No Reason at Motley Fool
05:28PM  Arena Prescription Sales Up: Stops Stock Slide at Seeking Alpha
03:25PM  Best stocks for legalized marijuana and more at MarketWatch
11:20AM  Arena Posts Wider Loss, Misses Ests Zacks
05:01AM  Q4 GDP estimate in focus for Wall Street at CNBC
12:10AM  Arena's Belviq Sales To Hit $150 Million In 2014? at Seeking Alpha
27-Feb-14 07:42PM  Arena Falls On Quarterly Results at Seeking Alpha
07:25PM  Arena Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:35PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:22PM  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 Arena Pharmaceuticals Earnings Release - After Market Close CCBN
01:49AM  Arena Earnings On Tap at Seeking Alpha
26-Feb-14 12:01AM  Arena Pharmaceuticals, Inc. Earnings: What to Expect Thursday at Motley Fool
24-Feb-14 04:49PM  Cheaper Obesity Drugs Available (for Half of Some Americans) at Motley Fool
10:39AM  The 10 Most Heavily Shorted Bio-Pharma Stocks at TheStreet
21-Feb-14 08:44PM  Arena's Belviq Sales Continue Up As Others Decline at Seeking Alpha
09:59AM  Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc. at Motley Fool
20-Feb-14 08:00AM  Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 PR Newswire
14-Feb-14 07:21PM  Arena Prescriptions Tracking With Expectations at Seeking Alpha
06:31PM  Why Arena Pharmaceuticals, Inc. Investors Should Remain Wary at Motley Fool
10:58AM  Arena Pharmaceuticals: Is The Stock Attractively Priced? at Seeking Alpha
09:16AM  You Should Be Cautious Investing In Orexigen And Arena at Seeking Alpha
09:15AM  Arena Pharmarceuticals and Chelsea Therapeutics International Ltd Could Be Today's Biggest Movers in Healthcare at Motley Fool
12-Feb-14 02:41PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
02:36PM  Can These Obesity Drug Stocks Bounce Back in 2014? at Motley Fool
08:00AM  Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil PR Newswire
11-Feb-14 09:06AM  Todays Top Biotech Stories: Mallinckrodt, Regeneron, Arena, and Omeros at Motley Fool
08:43AM  Arena Pharmaceuticals Secures Belviq Deal With CVS Caremark at Wall St. Cheat Sheet
10-Feb-14 12:50PM  Arena rallies after partner announces broader coverage for Belviq at theflyonthewall.com +7.17%
11:48AM  Arena, Eisai announce Belviq deal with CVS AP
09:27AM  Arena Reaches Critical Point On Insurance Coverage at Seeking Alpha
08:00AM  Arena Pharmaceuticals Reports Coverage for BELVIQ® (lorcaserin HCl) CIV Now Greater Than 50% of Insured Commercial Lives PR Newswire
07-Feb-14 08:26PM  Arena's Belviq Sees Modest Weekly Growth at Seeking Alpha
06:00AM  Biotech Stock Mailbag: Furiex, La Jolla Pharma, Sarepta at TheStreet
05-Feb-14 08:00AM  Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire
04-Feb-14 09:32AM  A Deeper Look At Arena Anti-Obesity Sales at Seeking Alpha
03-Feb-14 09:17PM  Arena Investors Look To Eisai Quarterly Report at Seeking Alpha -5.69%
06:08PM  Not What the Obesity Doctor Ordered at Motley Fool
05:12PM  Boomers take midlife cues to pursue passions at USA TODAY
09:01AM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
31-Jan-14 02:09PM  Arena's Belviq Sees Traction Slip Ahead Of Advertising at Seeking Alpha -7.32%
02:09PM  Arena's Belviq Sees Traction Slip Ahead Of Advertising
27-Jan-14 05:34PM  Are Smoking Cessation Drugs Better Than Nicotine-based Products? at Motley Fool -5.33%
24-Jan-14 06:38PM  Italian swimsuit company signs on as FINA sponsor AP
06:38PM  Italian swimsuit company signs on as FINA sponsor
03:54PM  Arena Investors Await Strong Sales Data at Seeking Alpha
03:54PM  Arena Investors Await Strong Sales Data
18-Jan-14 02:07PM  Will Orexigen Win the Obesity Drug War? at Motley Fool
17-Jan-14 01:52PM  Arena's Belviq Scripts Showing Traction - Vivus As Well at Seeking Alpha -5.96%
01:52PM  Arena's Belviq Scripts Showing Traction - Vivus As Well
12:20PM  JPMorgan Healthcare Conference Highlights: Arena Pharmaceuticals, Inc. at Motley Fool
12:20PM  JPMorgan Healthcare Conference Highlights: Arena Pharmaceuticals, Inc.
16-Jan-14 05:14PM  Here's What One of the Richest Americans Has Been Buying at Motley Fool +5.61%
09:21AM  Arena Pharmaceuticals - Why I Believe It Is The Next Major Biotech at Seeking Alpha
09:21AM  Arena Pharmaceuticals - Why I Believe It Is The Next Major Biotech
04:55AM  Arena Pharmaceuticals (ARNA) in Focus: Stock Rallies 7.2% Zacks
04:55AM  Arena Pharmaceuticals (ARNA) in Focus: Stock Rallies 7.2%
15-Jan-14 06:32PM  VIVUS, Inc. and Aetna Inc's New Weight Loss Plan at Motley Fool +7.18%
06:32PM  VIVUS, Inc. and Aetna Inc's New Weight Loss Plan
04:02AM  Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Year at Seeking Alpha
04:02AM  Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Year
14-Jan-14 06:46PM  [video] Belviq: the New FDA Approved Obesity-Fighting Drug at Bloomberg
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. Its products under development include APD811, an agonist of the prostacyclin receptor, which has completed single- and multiple-ascending dose Phase I trials for the treatment of pulmonary arterial hypertension; and temanogrel, an inverse agonist of the serotonin 2A receptor for the treatment of thrombotic diseases, which has completed single- and multiple-ascending dose Phase I trials. The company's products under development also comprise APD334, an agonist of the sphingosine 1-phosphate subtype 1 receptor for the treatment of conditions related to autoimmune diseases, which has completed Phase I single-ascending dose trial; and APD371, an agonist of the cannabinoid receptor 2 that is in Phase I single-ascending dose trial for the treatment of pain. It also manufactures drug products under a manufacturing services agreement for Siegfried AG. The company was founded in 1997 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nova Tina SusanDirectorApr 14Option Exercise4.7035,000164,35053,728Apr 15 09:59 PM
Nova Tina SusanDirectorApr 14Sale6.2235,000217,76318,728Apr 15 09:59 PM
BELCHER DONALD DDirectorApr 01Option Exercise6.301,90512,00270,633Apr 02 08:34 PM
SHANAHAN WILLIAM R JRSVP & Chief Medical OfficerApr 01Option Exercise6.3060,000378,00095,000Apr 02 08:35 PM
SHANAHAN WILLIAM R JRSVP & Chief Medical OfficerApr 01Sale6.3760,000382,01435,000Apr 02 08:35 PM
BELCHER DONALD DDirectorApr 01Sale6.451,90512,28768,728Apr 02 08:34 PM
SPECTOR STEVEN WEVP, General Counsel & SecMar 04Option Exercise1.4925,00037,250126,794Mar 05 08:03 PM
SPECTOR STEVEN WEVP, General Counsel & SecMar 04Sale7.0125,000175,250101,794Mar 05 08:03 PM
LIEF JACKChairman, President and CEOJan 17Option Exercise6.00100,000600,000683,704Jan 17 07:18 PM
LIEF JACKChairman, President and CEOJan 17Sale7.81100,000781,260583,704Jan 17 07:18 PM
BEHAN DOMINIC PEVP & Chief Scientific OfficerJan 10Option Exercise6.0033,332199,992516,332Jan 13 08:43 PM
BEHAN DOMINIC PEVP & Chief Scientific OfficerJan 10Sale6.2533,332208,325483,000Jan 13 08:43 PM
SPECTOR STEVEN WEVP, General Counsel & SecJan 09Option Exercise6.0033,334200,004135,128Jan 13 08:44 PM
BELCHER DONALD DDirectorJan 09Option Exercise6.0030,000180,00098,728Jan 13 08:45 PM
BICE SCOTT HDirectorJan 09Option Exercise6.0025,000150,00048,628Jan 13 08:46 PM
BICE SCOTT HDirectorJan 09Sale6.1025,000152,50023,628Jan 13 08:46 PM
BELCHER DONALD DDirectorJan 09Sale6.1530,000184,50068,728Jan 13 08:45 PM
SPECTOR STEVEN WEVP, General Counsel & SecJan 09Sale6.1033,334203,337101,794Jan 13 08:44 PM
SPECTOR STEVEN WEVP, General Counsel & SecNov 12Option Exercise1.4920,00029,80091,420Nov 13 07:46 PM
SPECTOR STEVEN WEVP, General Counsel & SecNov 12Sale5.1920,000103,71071,420Nov 13 07:46 PM
BEHAN DOMINIC PEVP & Chief Scientific OfficerSep 10Option Exercise1.57200,000314,000653,000Sep 11 08:34 PM
BEHAN DOMINIC PEVP & Chief Scientific OfficerSep 10Sale6.31200,0001,261,020453,000Sep 11 08:34 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 05Option Exercise1.4920,00029,80091,046Sep 06 07:13 PM
SPECTOR STEVEN WEVP, General Counsel & SecSep 05Sale6.5420,000130,72671,046Sep 06 07:13 PM
Audet Craig MichaelSVP, Opn & Head Glob Reg AfrsMay 21Option Exercise1.5783,750131,71398,750May 21 08:16 PM
Audet Craig MichaelSVP, Opn & Head Glob Reg AfrsMay 21Sale8.0083,750670,00015,000May 21 08:16 PM